Technical Analysis for PVCT - Provectus Pharma

Grade Last Price % Change Price Change
grade B 0.0625 -1.57% -0.0010
PVCT closed down 1.57 percent on Friday, January 24, 2020, on 55 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical PVCT trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
200 DMA Support Bullish 0.00%
Spinning Top Other 0.00%
Doji - Bullish? Reversal 0.00%
Fell Below 20 DMA Bearish -1.57%
Fell Below 50 DMA Bearish -1.57%
Overbought Stochastic Strength -1.57%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.02%
Older signals for PVCT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company. The Company is engaged in developing pharmaceuticals for oncology and dermatology indications. The Company is focused on developing its prescription drug candidates, PV-10 and PH-10. It is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer and breast cancer. It is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions, such as psoriasis and atopic dermatitis, a type of eczema. In addition to clinical trials, patients enrolled in the expanded access or compassionate use program for PV-10 are also receiving PV-10 treatments for cutaneous and subcutaneous cancer indications. The Company also focuses on over-the-counter (OTC) products and various other non-core technologies. PV-10 is a sterile injectable form of rose bengal disodium (Rose Bengal), for direct injection into tumors.
RTT Biopharmaceutical Pharmaceuticals Chemical Compounds Organic Compounds Cancers Breast Cancer Autoimmune Diseases Psoriasis Ophthalmology Atopic Dermatitis Chloroarenes Tumors Dermatitis Metastatic Melanoma Liver Cancer Eczema Phenols Aromatic Compounds

Is PVCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.075
52 Week Low 0.0111
Average Volume 384,840
200-Day Moving Average 0.0614
50-Day Moving Average 0.0647
20-Day Moving Average 0.0639
10-Day Moving Average 0.0658
Average True Range 0.0058
ADX 14.08
+DI 12.3581
-DI 19.1677
Chandelier Exit (Long, 3 ATRs ) 0.0526
Chandelier Exit (Short, 3 ATRs ) 0.0684
Upper Bollinger Band 0.0712
Lower Bollinger Band 0.0566
Percent B (%b) 0.4
BandWidth 22.8482
MACD Line 0.0004
MACD Signal Line 0.0005
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0705
Resistance 3 (R3) 0.0705 0.0680 0.0691
Resistance 2 (R2) 0.0680 0.0659 0.0679 0.0687
Resistance 1 (R1) 0.0652 0.0647 0.0640 0.0652 0.0682
Pivot Point 0.0627 0.0627 0.0620 0.0626 0.0627
Support 1 (S1) 0.0599 0.0606 0.0587 0.0599 0.0568
Support 2 (S2) 0.0574 0.0594 0.0573 0.0563
Support 3 (S3) 0.0546 0.0574 0.0559
Support 4 (S4) 0.0546